Showing results (91-100 of 150) with videos related to

Sort By:
Pageof 15
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2011
Phase I study of sunitinib and erlotinib in advanced nonsquamous non-small cell lung cancerShannon E O'Mahar, Toby C Campbell, Tien Hoang, et al.
Cancer Chemotherapy and Pharmacology|January 1, 2010
Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation studyFrancisco Robert, Alan Sandler, Joan H Schiller, et al.
Lab on a Chip|October 26, 2013
Paired diagnostic and pharmacodynamic analysis of rare non-small cell lung cancer cells enabled by the VerIFAST platformBenjamin P Casavant, Lindsay N Strotman, Jacob J Tokar, et al.
Analytica Chimica Acta|January 25, 2008
Effective monitoring for ractopamine residues in samples of animal origin by SPR biosensor and mass spectrometryColin S Thompson, Simon A Haughey, Imelda M Traynor, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 9, 2016
Assisted care as a baseline patient risk characteristic affecting the outcome of transcatheter aortic valve insertionMegan M Traynor, Kevin L Greason, Vuyisile T Nkomo, et al.
Head & Neck|June 28, 2013
Increased local failure risk with prolonged radiation treatment time in head and neck cancer treated with concurrent chemotherapyDonald M Cannon, Heather M Geye, Gregory K Hartig, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 26, 2013
Phase II study of everolimus-erlotinib in previously treated patients with advanced non-small-cell lung cancerB Besse, N Leighl, J Bennouna, et al.
Drug and Alcohol Dependence|February 20, 2021
Self-efficacy as a mediator of patient navigation interventions to engage persons living with HIV and substance useSharleen M Traynor, Lisa R Metsch, Lauren Gooden, et al.
Technology in Cancer Research & Treatment|December 3, 2008
Dose escalated, hypofractionated radiotherapy using helical tomotherapy for inoperable non-small cell lung cancer: preliminary results of a risk-stratified phase I dose escalation studyJ B Adkison, D Khuntia, S M Bentzen, et al.
Investigational New Drugs|February 25, 2009
A phase II trial of triapine (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503Anne M Traynor, Ju-Whei Lee, Gerald K Bayer, et al.
Pageof 15